{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T17:24:32Z","timestamp":1761845072766},"reference-count":31,"publisher":"Japanese Urological Association","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Jpn. j. urol"],"published-print":{"date-parts":[[2018,10,20]]},"DOI":"10.5980\/jpnjurol.109.184","type":"journal-article","created":{"date-parts":[[2019,10,17]],"date-time":"2019-10-17T18:06:25Z","timestamp":1571335585000},"page":"184-193","source":"Crossref","is-referenced-by-count":1,"title":["SALVAGE CRYOABLATION TARGETING RECURRENT LESIONS AFTER DEFINITIVE RADIOTHERAPY FOR PROSTATE CANCER: IMPACT OF POST CRYOABLATION CHANGE IN URINARY AND SEXUAL FUNCTION"],"prefix":"10.5980","volume":"109","author":[{"given":"Kenta","family":"Miki","sequence":"first","affiliation":[{"name":"Department of Urology, Jikei University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shoji","family":"Kimura","sequence":"additional","affiliation":[{"name":"Department of Urology, Jikei University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hajime","family":"Ohnuma","sequence":"additional","affiliation":[{"name":"Department of Urology, Jikei University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keigo","family":"Sakanaka","sequence":"additional","affiliation":[{"name":"Department of Urology, Jikei University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Sasaki","sequence":"additional","affiliation":[{"name":"Department of Urology, Jikei University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiro","family":"Kimura","sequence":"additional","affiliation":[{"name":"Department of Urology, Jikei University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Takahashi","sequence":"additional","affiliation":[{"name":"Department of Pathology, Jikei University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shin","family":"Egawa","sequence":"additional","affiliation":[{"name":"Department of Urology, Jikei University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"4001","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Zumsteg ZS, Spratt DE, Romesser PB, Pei X, Zhang Z, Polkinghorn W, McBride S, Kollmeier M, Yamada Y and Zelefsky MJ: The natural history and predictors of outcome following biochemical relapse in the dose escalation era for prostate cancer patients undergoing definitive external beam radiotherapy. Eur Urol, 67 (6), 1009-1016, 2015.","DOI":"10.1016\/j.eururo.2014.09.028"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Zhou P, Chen MH, McLeod D, Carroll PR, Moul JW and D&apos;Amico AV: Predictors of prostate cancer-specific mortality after radical prostatectomy or radiation therapy. J Clin Oncol, 23 (28), 6992-6998, 2005.","DOI":"10.1200\/JCO.2005.01.2906"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Lee WR, Hanks GE and Hanlon A: Increasing prostate-specific antigen profile following definitive radiation therapy for localized prostate cancer: clinical observations. J Clin Oncol, 15 (1), 230-238, 1997.","DOI":"10.1200\/JCO.1997.15.1.230"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Tran H, Kwok J, Pickles T, Tyldesley S and Black PC: Underutilization of local salvage therapy after radiation therapy for prostate cancer. Urol Oncol, 32 (5), 701-706, 2014.","DOI":"10.1016\/j.urolonc.2013.12.014"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Alongi F, De Bari B, Campostrini F, Arcangeli S, Matei DV, Lopci E, Petralia G, Bellomi M, Chiti A, Magrini SM, Scorsetti M, Orecchia R and Jereczek-Fossa BA: Salvage therapy of intraprostatic failure after radical external-beam radiotherapy for prostate cancer: a review. Crit Rev Oncol Hematol, 88 (3), 550-563, 2013.","DOI":"10.1016\/j.critrevonc.2013.07.009"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Nguyen PL, D&apos;Amico AV, Lee AK and Suh WW: Patient selection, cancer control, and complications after salvage local therapy for postradiation prostate-specific antigen failure: a systematic review of the literature. Cancer, 110 (7), 1417-1428, 2007.","DOI":"10.1002\/cncr.22941"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Nguyen PL, Alibhai SM, Basaria S, D&apos;Amico AV, Kantoff PW, Keating NL, Penson DF, Rosario DJ, Tombal B and Smith MR: Adverse effects of androgen deprivation therapy and strategies to mitigate them. Eur Urol, 67 (5), 825-836, 2015.","DOI":"10.1016\/j.eururo.2014.07.010"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Roach M 3<sup>rd<\/sup>, Hanks G, Thames H Jr, Schellhammer P, Shipley WU, Sokol GH and Sandler H: Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference. Int J Radiat Oncol Biol Phys, 65, 965-974, 2006.","DOI":"10.1016\/j.ijrobp.2006.04.029"},{"key":"9","doi-asserted-by":"publisher","unstructured":"9) Satoh T, Matsumoto K, Fujita T, Tabata K, Okusa H, Tsuboi T, Arakawa T, Irie A, Egawa S and Baba S: Cancer core distribution in patients diagnosed by extended transperineal prostate biopsy. Urology, 66 (1), 114-118, 2005.","DOI":"10.1016\/j.urology.2005.01.051"},{"key":"10","unstructured":"10) Common Terminology Criteria for Adverse Events (CTCAE) Version 4.03. Available from URL: https:\/\/evs.nci.nih.gov\/ftp1\/CTCAE\/CTCAE_4.03_2010-06-14_QuickReference_8.5x11.pdf"},{"key":"11","unstructured":"11) NCCN Guideline 2016 v4."},{"key":"12","doi-asserted-by":"crossref","unstructured":"13) Chade DC, Shariat SF, Cronin AM, Savage CJ, Karnes RJ, Blute ML, Briganti A, Montorsi F, van der Poel HG, Van Poppel H, Joniau S, Godoy G, Hurtado-Coll A, Gleave ME, Dall&apos;Oglio M, Srougi M, Scardino PT and Eastham JA: Salvage radical prostatectomy for radiation-recurrent prostate cancer: A multi-institutional collaboration. Eur Urol, 60 (2), 205-210, 2011.","DOI":"10.1016\/j.eururo.2011.03.011"},{"key":"13","doi-asserted-by":"crossref","unstructured":"14) Gotto GT, Yunis LH, Vora K, Eastham JA, Scardino PT and Rabbani F: Impact of prior prostate radiation on complications after radical prostatectomy. J Urol, 184 (1), 136-142, 2010.","DOI":"10.1016\/j.juro.2010.03.031"},{"key":"14","doi-asserted-by":"crossref","unstructured":"15) Bates AS, Samavedi S, Kumar A, Mouraviev V, Rocco B, Coelho R, Palmer K and Patel VR: Salvage robot assisted radical prostatectomy: A propensity matched study of perioperative, oncological and functional outcomes. Eur J Surg Oncol, 41 (11), 1540-1546, 2015.","DOI":"10.1016\/j.ejso.2015.06.002"},{"key":"15","doi-asserted-by":"crossref","unstructured":"16) Kaffenberger SD, Keegan KA, Bansal NK, Morgan TM, Tang DH, Barocas DA, Penson DF, Davis R, Clark PE, Chang SS, Cookson MS, Herrell SD and Smith JA: Salvage robotic assisted laparoscopic radical prostatectomy: A single institution, 5-year experience. J Urol, 189 (2), 507-513, 2013.","DOI":"10.1016\/j.juro.2012.09.057"},{"key":"16","doi-asserted-by":"crossref","unstructured":"17) Zugor V, Labanaris AP, Porres D, Heidenreich A and Witt JH: Robot-assisted radical prostatectomy for the treatment of radiation-resistant prostate cancer: Surgical, oncological and short-term functional outcomes. Urol Int, 92 (1), 20-26, 2014.","DOI":"10.1159\/000351948"},{"key":"17","doi-asserted-by":"crossref","unstructured":"18) Peters M, Hoekstra C, van der Voort van Zyp J, Westendorp H, von de Pol S, Moerland M, Maenhout M, Kattevilder R and van Vulpen M: Rectal dose constraints for salvage iodine-125 prostate brachytherapy. Brachytherapy, 15, 85-93, 2016.","DOI":"10.1016\/j.brachy.2015.10.004"},{"key":"18","doi-asserted-by":"crossref","unstructured":"19) Peters M, van der Voort van Zyp J, Hoekstra C, Westendorp H, van de Pol S, Moerland M, Maenhout M, Kattevilder R and van Vulpen M: Urethral and bladder dosimetry of total and focal salvage iodine-125 prostate brachytherapy: Late toxicity and dose constraints. Radiother Oncol, 117, 262-269, 2015.","DOI":"10.1016\/j.radonc.2015.08.018"},{"key":"19","unstructured":"20) Crook J: RTOG 0526 protocol information: A prospective phase II trial of transperineal ultrasound-guided brachytherapy for locally recurrent prostate adenocarcinoma following external beam radiotherapy. Available at: https:\/\/www.rtog.org\/ClinicalTrials\/ProtocolTable\/StudyDetails.aspx?study=0526 Updated 2014."},{"key":"20","doi-asserted-by":"crossref","unstructured":"21) Crook JM, O&apos;Callaghan CJ, Duncan G, Dearnaley DP, Higano CS, Horwitz EM, Frymire E, Malone S, Chin J, Nabid A, Warde P, Corbett T, Angyalfi S, Goldenberg SL, Gospodarowicz MK, Saad F, Logue JP, Hall E, Schellhammer PF, Ding K and Klotz L: Intermittent androgen suppression for rising PSA level after radiotherapy. N Engl J Med, 367 (10), 895-903, 2012.","DOI":"10.1056\/NEJMoa1201546"},{"key":"21","doi-asserted-by":"crossref","unstructured":"22) Keating NL, O&apos;Malley AJ and Smith MR: Diabetes and cardiovascular disease during androgen deprivation therapy for prostate cancer. J Clin Oncol, 24, 4448-4456, 2006.","DOI":"10.1200\/JCO.2006.06.2497"},{"key":"22","doi-asserted-by":"publisher","unstructured":"23) de Castro A, Bahn D, Leslie S, Shoji S, Silverman P, Desai M, Gill IS and Ukimura O: Salvage focal and salvage total cryoablation for locally recurrent prostate cancer after primary radiation therapy. BJU International, 112, 298-307, 2013.","DOI":"10.1111\/bju.12151"},{"key":"23","doi-asserted-by":"crossref","unstructured":"24) Horwitz EM, Vicini FA, Ziaja EL, Dmuchowski CF, Stromberg JS and Martinez AA: The correlation between the ASTRO Consensus Panel definition of biochemical failure and clinical outcome for patients with prostate cancer treated with external beam irradiation. American Society of Therapeutic Radiology and Oncology. Int J Radiat Oncol Biol Phys., 41 (2), 267-72, 1998.","DOI":"10.1016\/S0360-3016(98)00078-9"},{"key":"24","doi-asserted-by":"crossref","unstructured":"25) Eisenberg ML and Shinohara K: Partial salvage cryoablation of the prostate for recurrent prostate cancer after radiotherapy failure. Urology, 72 (6), 1315-18, 2008.","DOI":"10.1016\/j.urology.2008.03.040"},{"key":"25","doi-asserted-by":"crossref","unstructured":"26) Williams AK, Martinez CH, Lu C, Ng CK, Pautler SE and Chin JL: Disease-free survival following salvage cryotherapy for biopsy-proven radio-recurrent prostate cancer. Eur Urol, 260, 405-410, 2011.","DOI":"10.1016\/j.eururo.2010.12.012"},{"key":"26","doi-asserted-by":"crossref","unstructured":"27) Kongnyuy M, Halpern DM, Liu CC, Kosinski KE, Habibian DJ, Corcoran AT and Katz AE: 3-T multiparametric MRI characteristics of prostate cancer patients suspicious for biochemical recurrence after primary focal cryosurgery (hemiablation). Int Urol Nephrol, 49, 1947-1954, 2017.","DOI":"10.1007\/s11255-017-1670-3"},{"key":"27","doi-asserted-by":"crossref","unstructured":"28) Ng CK, Moussa M, Downey DB and Chin JL: Salvage cryoablation of the prostate: Followup and analysis of predictive factors for outcome. J Urol, 178, 1253-1257, 2007.","DOI":"10.1016\/j.juro.2007.05.137"},{"key":"28","doi-asserted-by":"crossref","unstructured":"29) Pisters LL, Rewcastle JC, Donnelly BJ, Lugnai FM, Katz AE and Jones JS: Salvage prostate cryoablation: Initial results from the cryo on-line data registry. J Urol, 180, 559-563, 2008.","DOI":"10.1016\/j.juro.2008.04.005"},{"key":"29","doi-asserted-by":"crossref","unstructured":"30) Spiess PE, Levy DA, Pisters LL, Mouraviev V and Jones JS: Outcomes of salvage prostate cryotherapy stratified by pre-treatment PSA: Update from the COLD registry. World J Urol, 31, 1321-1325, 2013.","DOI":"10.1007\/s00345-012-0982-2"},{"key":"30","doi-asserted-by":"crossref","unstructured":"31) Amend B, Hennenlotter J, Kuehs U, Laible I, Anastasiadis A, Schilling D, Stenzl A and Sievert KD: Prostatic peripheral nerve distribution may impact the functional outcome of nerve-sparing prostatectomy. World J Urol, 31, 377-382, 2013.","DOI":"10.1007\/s00345-011-0791-z"},{"key":"31","doi-asserted-by":"crossref","unstructured":"32) Nielsen ME, Schaeffer EM, Marschke P and Walsh PC: High Anterior Release of the Levator Fascia Improves Sexual Function Following Open Radical Retropubic Prostatectomy. J Urol, 180, 2557-2564, 2008.","DOI":"10.1016\/j.juro.2008.08.047"}],"container-title":["The Japanese Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jpnjurol\/109\/4\/109_184\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,18]],"date-time":"2019-10-18T23:47:56Z","timestamp":1571442476000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jpnjurol\/109\/4\/109_184\/_article\/-char\/ja\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,20]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.5980\/jpnjurol.109.184","relation":{},"ISSN":["0021-5287","1884-7110"],"issn-type":[{"value":"0021-5287","type":"print"},{"value":"1884-7110","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,20]]}}}